Ignite Creation Date:
2025-12-25 @ 4:26 AM
Ignite Modification Date:
2026-03-01 @ 6:27 AM
Study NCT ID:
NCT04377620
Status:
TERMINATED
Last Update Posted:
2022-01-19
First Post:
2020-05-04
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Assessment of Efficacy and Safety of Ruxolitinib in Participants With COVID-19-Associated ARDS Who Require Mechanical Ventilation (RUXCOVID-DEVENT)
Sponsor:
Incyte Corporation
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2020-05-24
Start Date Type:
ACTUAL
Primary Completion Date:
2021-02-26
Primary Completion Date Type:
ACTUAL
Completion Date:
2021-02-26
Completion Date Type:
ACTUAL
First Submit Date:
2020-05-04
First Submit QC Date:
None
Study First Post Date:
2020-05-06
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2021-11-17
Results First Submit QC Date:
None
Results First Post Date:
2022-01-19
Results First Post Date Type:
ACTUAL
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2022-01-14
Last Update Post Date:
2022-01-19
Last Update Post Date Type:
ACTUAL